Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes: Effect of 1 Year's Cardiovascular Risk Reduction Therapy
Diabetes Care - United States
doi 10.2337/diacare.27.8.2049
Full Text
Open PDFAbstract
Available in full text
Date
July 26, 2004
Authors
Publisher
American Diabetes Association